Conflixis
Dallas, US · Founded 2022 · Delaware corporation · 14 employees on LinkedIn · 3 known investors
Conflixis provides a platform for managing conflicts of interest in healthcare by integrating provider disclosures, external data, and behavioral risk signals to help organizations ensure transparency and compliance across clinician and corporate relationships.
Also known as Conflixis
Founders & leadership
Board
Investors · 3
Reported raises · per SEC filings
Form D private placements$4.8M disclosed across 3 rounds · 2023–2024
▶$4.3MraisedOct 2024 · 7 investors · Other TechnologyRule 506(b)
- Aaron NarvaExecutive Officer, Director
- Jacquie Marshall SiegmundDirector
- Vincent WanDirector
- Offering amount
- $4.3M
- Amount sold
- $4.3M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$275KraisedJan 2024 · 7 investors · Other TechnologyRule 506(b)
- Vincent WanDirector
- Joseph BergenDirector
- Aaron NarvaExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $275K
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$200KraisedApr 2023 · 5 investors · Other TechnologyRule 506(b)
- Joseph BergenDirector
- Vincent WanDirector
- Aaron NarvaExecutive Officer, Director
- Offering amount
- $200K
- Amount sold
- $200K
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026Conflixis develops software for managing conflicts of interest (COI) in healthcare organizations. The platform is positioned as a replacement for manual review processes and legacy tools, covering the full COI program lifecycle: disclosure collection, review, routing, reporting and resolution. Disclosure forms can be pre-populated with Open Payments data, and providers can submit information via document uploads, prior-year forms or web links; the company states this can save up to four hours per provider, with an average of 30 minutes.
Additional functionality includes automated review and scoring that flags critical relationships while auto-approving lower-risk ones (stated savings of up to two hours per relationship, averaging 15 minutes), an AI report builder for extracting data and identifying year-over-year trends without involving internal data teams, integration with supplier, HR and other datasets for risk management, and AI-assisted generation of management plans from customer templates alongside bulk routing for review and approval.
Business model
Software platform sold to healthcare organizations to run their conflict-of-interest programs, with engagement beginning through demo requests and direct contact.
Traction
The company reports media coverage in Politico, The Wall Street Journal, USA Today and TechCrunch, and states it built the first national COI risk assessment ranking health systems and practice groups.
▸Full profile — market position, technology, go-to-market
Market position
Positions itself against manual COI review workflows and older compliance tools in healthcare. The company cites market statistics including 20% of hospital budgets spent on conflicted suppliers, 70% of conflicted relationships going undisclosed, more than $2.2B in COI-related fines in 2024, and more than 50% of providers having a disclosable relationship. Its site notes it has been featured in Politico, The Wall Street Journal, USA Today and TechCrunch.
Technology
Workflow automation combined with AI features, including an AI report builder for data extraction and trend analysis, automated risk-based scoring of disclosed relationships, and auto-filled management plans generated from customer templates. Disclosure forms integrate external Open Payments data and can ingest document uploads, prior forms and web links; the platform also connects to supplier and HR datasets.
Go-to-market
Direct sales motion driven by the company website, with "book a demo" and contact forms. As a lead-generation offer, Conflixis promotes a free, limited-time national COI risk assessment that ranks health systems and practice groups across legal, medical necessity, procurement and research integrity risk.
Health systems, academic medical centers, research universities and physician practice groups, and the compliance functions that operate their COI programs.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 5
by search overlap
Companies competing with Conflixis for the same Google search keywords, organic and paid, via search-intersection analysis.
Legal entities · 1
corporate structure▸Research sources · 1
primary sources listed
- Conflixisconflixis.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Conflixis do?
- Conflixis is a healthcare compliance platform that automates conflict-of-interest disclosure, review and management.
- Who are Conflixis's investors?
- Conflixis's investors include Lerer Hippeau, mark vc, Origin Ventures.
- How much funding has Conflixis raised?
- Conflixis has disclosed $4.8M raised across 3 rounds.
- Where is Conflixis headquartered?
- Conflixis is headquartered in Dallas, US.